Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

VEGF

  • Open Access
    Fucoidan Treatment Leads to Attenuated Growth Factor Signaling and Reduced Proliferation in Neuroblastoma Cells
    NIKLAS WEBER, NINA SOPHIE POMMERT, MEIKE KAEHLER, INGOLF CASCORBI, SUSANNE ALBAN and VICKI WAETZIG
    Anticancer Research July 2025, 45 (7) 2749-2762; DOI: https://doi.org/10.21873/anticanres.17644
  • You have access
    Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial
    YASUYOSHI SATO, HIROHARU YAMASHITA, KOICHI YAGI, SACHIYO NOMURA and YASUYUKI SETO
    Anticancer Research July 2024, 44 (7) 3125-3131; DOI: https://doi.org/10.21873/anticanres.17126
  • Open Access
    Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review
    TAIGO KATO, SHIMON KURASAWA, KENTARO TAKEZAWA, YUTAKA FUJIWARA, YOSHINARI YASUDA and YUICHI ANDO
    Anticancer Research March 2024, 44 (3) 889-894; DOI: https://doi.org/10.21873/anticanres.16882
  • You have access
    Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer
    JONG-HO LEE
    Anticancer Research January 2023, 43 (1) 75-84; DOI: https://doi.org/10.21873/anticanres.16136
  • You have access
    Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ Measurements
    MICHAEL I. ITA, JIANG H. WANG, CYNTHIA C. HEFFRON, DEREK G. POWER, YVONNE NOLAN, ANDRÉ TOULOUSE, CHRIS C.H. LIM, NOEL FANNING and HENRY P. REDMOND
    Anticancer Research February 2022, 42 (2) 801-810; DOI: https://doi.org/10.21873/anticanres.15538
  • You have access
    Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells
    SHANG-YOU YANG, ELKA GARCIA, WILL XIA and ANYU WANG
    Anticancer Research October 2021, 41 (10) 4781-4787; DOI: https://doi.org/10.21873/anticanres.15293
  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
    MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU
    Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809
  • You have access
    Antitumor Activity of Rivoceranib Against Canine Mammary Gland Tumor Cell Lines
    JEONG-HA LEE, QIANG LI, JU-HYUN AN, HYUNG-KYU CHAE, JIN-WOO CHOI, BUM-JIN KIM, WOO-JIN SONG and HWA-YOUNG YOUN
    Anticancer Research October 2019, 39 (10) 5483-5494; DOI: https://doi.org/10.21873/anticanres.13741
  • You have access
    State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
    RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA
    Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire